Independent Association Between Nocturnal Intermittent Hypoxemia and Metabolic Dyslipidemia



      There is growing evidence from animal models that intermittent hypoxemia (IH) may induce dyslipidemia. Altered lipid metabolism may contribute to the increased cardiovascular risk observed in obstructive sleep apnea (OSA). In this multisite, cross-sectional study, we tested the hypothesis that there is an independent association between nocturnal IH and dyslipidemia in OSA.


      Fasting serum lipid levels were measured in 2,081 patients (638 women) undergoing nocturnal recording for clinical suspicion of OSA. Multivariate regression analyses were performed to evaluate the independent associations between oxygen desaturation index (ODI) and lipid profile after adjustment for potential confounders, including components of the metabolic syndrome (MS) or the MS itself. Adjusted OR for metabolic dyslipidemia (triglycerides [TG] ≥ 150 mg/dL and high-density lipoprotein cholesterol [HDL-C] ≤ 50 mg/dL for women and ≤ 40 mg/dL for men) according to quartiles of ODI were determined by logistic regression.


      Total cholesterol and low-density lipoprotein cholesterol were not associated with ODI. In contrast, nocturnal IH and OSA severity were associated with higher TG levels and lower HDL-C levels after adjustment for confounding factors. The association between ODI and TG and HDL-C levels was independent of the MS. Adjusted OR (95% CIs) for metabolic dyslipidemia were 1 (reference), 1.56 (1.24-1.96), 1.72 (1.29-2.29), and 1.93 (1.55-2.41) for ODI ≤ 7, > 7 to ≤ 18, > 18 to ≤ 38, and > 38, respectively (P <.0001 for linear trend).


      Nocturnal IH is independently associated with metabolic dyslipidemia, which may predispose patients with OSA to a higher risk of cardiovascular disease.
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bradley TD
        • Floras JS
        Obstructive sleep apnoea and its cardiovascular consequences.
        Lancet. 2009; 373: 82-93
        • Redline S
        • Yenokyan G
        • Gottlieb DJ
        • et al.
        Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study.
        Am J Respir Crit Care Med. 2010; 182: 269-277
        • Gottlieb DJ
        • Yenokyan G
        • Newman AB
        • et al.
        Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study.
        Circulation. 2010; 122: 352-360
        • Punjabi NM
        • Caffo BS
        • Goodwin JL
        • et al.
        Sleep-disordered breathing and mortality: a prospective cohort study.
        PLoS Med. 2009; 6: e1000132
        • Stamler J
        • Vaccaro O
        • Neaton JD
        • Wentworth D
        Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.
        Diabetes Care. 1993; 16: 434-444
        • Jacobs D
        • Blackburn H
        • Higgins M
        • et al.
        Report of the Conference on Low Blood Cholesterol: mortality associations.
        Circulation. 1992; 86: 1046-1060
        • Chen Z
        • Peto R
        • Collins R
        • MacMahon S
        • Lu J
        • Li W
        Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.
        BMJ. 1991; 303: 276-282
        • Rana JS
        • Visser ME
        • Arsenault BJ
        • et al.
        Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
        Int J Cardiol. 2010; 143: 399-404
        • Arsenault BJ
        • Rana JS
        • Stroes ES
        • et al.
        Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
        J Am Coll Cardiol. 2009; 55: 35-41
        • Ballantyne CM
        • Olsson AG
        • Cook TJ
        • Mercuri MF
        • Pedersen TR
        • Kjekshus J
        Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
        Circulation. 2001; 104: 3046-3051
        • Li J
        • Thorne LN
        • Punjabi NM
        • et al.
        Intermittent hypoxia induces hyperlipidemia in lean mice.
        Circ Res. 2005; 97: 698-706
        • Li J
        • Grigoryev DN
        • Ye SQ
        • et al.
        Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice.
        J Appl Physiol. 2005; 99: 1643-1648
        • Drager LF
        • Jun J
        • Polotsky VY
        Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis.
        Curr Opin Endocrinol Diabetes Obes. 2010; 17: 161-165
        • Gagnadoux F
        • Le Vaillant M
        • Goupil F
        • IRSR Sleep Cohort Group
        • et al.
        Influence of marital status and employment status on long-term adherence with continuous positive airway pressure in sleep apnea patients.
        PLoS ONE. 2011; 6: e22503
        • Priou P
        • Le Vaillant M
        • Meslier N
        • IRSR Sleep Cohort Group
        • et al.
        Independent association between obstructive sleep apnea severity and glycated hemoglobin in adults without diabetes.
        Diabetes Care. 2012; 35: 1902-1906
        • Barceló A
        • Piérola J
        • de la Peña M
        • et al.
        Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea.
        Eur Respir J. 2011; 37: 1418-1423
        • Botros N
        • Concato J
        • Mohsenin V
        • Selim B
        • Doctor K
        • Yaggi HK
        Obstructive sleep apnea as a risk factor for type 2 diabetes.
        Am J Med. 2009; 122: 1122-1127
        • Johns MW
        A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale.
        Sleep. 1991; 14: 540-545
      1. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.
        Sleep. 1999; 22: 667-689
        • Liang KY
        • Zeger SL
        Regression analysis for correlated data.
        Annu Rev Public Health. 1993; 14: 43-68
      2. Togeiro SM, Carneiro G, Ribeiro Filho FF et al. Consequences of obstructive sleep apnea on metabolic profile: a population-based survey. Obesity (Silver Spring). In press. doi:10.1038/oby.2012.146.

        • Selvin E
        • Steffes MW
        • Zhu H
        • et al.
        Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.
        N Engl J Med. 2010; 362: 800-811
      3. Sopkova Z, Berneis K, Rizzo M et al. Size and subclasses of low-density lipoproteins in patients with obstructive sleep apnea Angiology. In press. doi:10.1177/0003319711433811.

        • Bush NC
        • Basu R
        • Rizza RA
        • Nair KS
        • Khosla S
        • Jensen MD
        Insulin-mediated FFA Suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity.
        J Clin Endocrinol Metab. 2012; 97: 4130-4138
        • Polotsky VY
        • Li J
        • Punjabi NM
        • et al.
        Intermittent hypoxia increases insulin resistance in genetically obese mice.
        J Physiol. 2003; 552: 253-264
        • Punjabi NM
        • Shahar E
        • Redline S
        • Gottlieb DJ
        • Givelber R
        • Resnick HE
        • Sleep Heart Health Study Investigators
        Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study.
        Am J Epidemiol. 2004; 160: 521-530
        • Drager LF
        • Jun JC
        • Polotsky VY
        Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea.
        Best Pract Res Clin Endocrinol Metab. 2010; 24: 843-851
        • Robinson GV
        • Pepperell JC
        • Segal HC
        • Davies RJ
        • Stradling JR
        Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials.
        Thorax. 2004; 59: 777-782
        • Kohler M
        • Stoewhas AC
        • Ayers L
        • et al.
        Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial.
        Am J Respir Crit Care Med. 2011; 184: 1192-1199
        • Phillips CL
        • Yee BJ
        • Marshall NS
        • Liu PY
        • Sullivan DR
        • Grunstein RR
        Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial.
        Am J Respir Crit Care Med. 2011; 184: 355-361
        • Sharma SK
        • Agrawal S
        • Damodaran D
        • et al.
        CPAP for the metabolic syndrome in patients with obstructive sleep apnea.
        N Engl J Med. 2011; 365: 2277-2286
        • Drager LF
        • Lorenzi-Filho G
        CPAP for obstructive sleep apnea and the metabolic syndrome.
        N Engl J Med. 2012; 366: 964